Iradimed (IRMD) Shareholder's Equity Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Iradimed | 1.17 Bn | 1.11 Bn | 16.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.33% |
| Dec 31, 2025 | 9.04% |
| Sep 30, 2025 | 10.13% |
| Jun 30, 2025 | 10.07% |
| Mar 31, 2025 | 9.18% |
| Dec 31, 2024 | 9.35% |
| Sep 30, 2024 | 10.01% |
| Jun 30, 2024 | 11.06% |
| Mar 31, 2024 | 11.26% |
| Dec 31, 2023 | 11.23% |
| Sep 30, 2023 | 13.21% |
| Jun 30, 2023 | 25.05% |
| Mar 31, 2023 | 804.63% |
| Dec 31, 2022 | 17.47% |
| Sep 30, 2022 | 16.77% |
| Jun 30, 2022 | 16.06% |
| Mar 31, 2022 | 14.33% |
| Dec 31, 2021 | 17.75% |
| Sep 30, 2021 | 17.25% |
| Jun 30, 2021 | 17.92% |
| Mar 31, 2021 | 16.62% |
| Dec 31, 2020 | 13.96% |
| Sep 30, 2020 | 16.65% |
| Jun 30, 2020 | 18.40% |
| Mar 31, 2020 | 20.38% |
| Dec 31, 2019 | 21.59% |
| Sep 30, 2019 | 20.77% |
| Jun 30, 2019 | 45.22% |
| Dec 31, 2018 | 50.55% |